Bcl-x gene expression in Hodgkin's disease

Leukemia and Lymphoma

Volumn 23, Issue 1-2, 1996, Pages 143-146

  Schlaifer, Daniel ^a   Krajewski, Stanislaw ^b   Rigal Huguet, Françoise ^a   Laurent, Guy ^a   Pris, Jacques ^a   Delsol, Georges ^a   Reed, John C ^b   Brousset, Pierre ^a  

^a CHU PURPAN   (France)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Bcl x gene; Gene expression; Hodgkin's disease

Indexed keywords

PROTEIN BCL 2;

ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; ONCOGENE; PRIORITY JOURNAL;

EID: 0029804097     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054813     Document Type: Article

References (39)

1. Kerr, J. F. R., Wyllie, A. H., Currie, A. R. (1972) Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br. J Cancer, 26, 239-257.
2. Wyllie, A. H., Kerr, J. F. R., Currie, A. R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306
3. Fairbairn, L. J., Cowling, G. J., Reipert, B. M., Dexter, T. M. (1993) Suppression of apoptosis allows differentiation and development of a multipotent hematopoietic cell line in the absence of added growth factors. Cell, 74, 823-832.
4. Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M., Taylor, T. R. (1990) Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature, 343, 76-79.
5. Cohen, J. J., Duke, R C. (1984) Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol., 132, 38-42.
6. Sellins, K. S., Cohen, J. J. (1987) Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol., 139, 3199-3206.
7. Warters, R. L. (1992) Radiation-induced apoptosis in a murine T-cell hybridoma. Cancer Res., 52, 883-890.
8. Barry, M. A., Behnke, C. A., Eastman, A. (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40, 2353-2362.
9. Evans, D. L., Dive, C. (1993) Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res., 53, 2133-2139.
10. Gorczyca, W., Gong, J., Ardelt, B., Traganos, F., Darzynkiewicz, Z. (1993) The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res., 53, 3186-3192.
11. Steller, H. (1995) Mechanisms and genes of cellular suicide. Science, 267, 1445-1449.
12. Cleary, M. L , Smith, S. D., Sklar, J. (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation Cell, 47, 19-28.
13. Tsujimoto, Y , Croce, C. M. (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83, 5214-5218.
14. Reed, J. C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6.
15. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., Thompson, C. B. (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
16. Oltvai, Z. N., Milliman, C. L., Korsmeyer, S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell, 74, 609-619.
17. Sate, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H. G., Reed, J. C (1994) Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA, 91, 9238-9242.
18. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B , Korsmeyer, S. J. (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA, 92, 7834-7838.
19. Gougeon, M. L., Montagnier, L. (1993) Apoptosis in AIDS. Science, 260, 1269-1270.
20. Raza, A., Gezer, S., Mundle, S., Gao, X-Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S., Preisler, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268-276.
21. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
22. Pezzella, F., Gatter, K. (1995) What is the value of bcl-2 protein detection for histopathologists? Histopathology, 26, 89-93.
23. Schlaifer, D., Brousset, P., Attal, M., Massip, P., Payen, C., Marchou, B., Huguet, F., Muller, C., Laurent, G., Pris, J., Delsol, G (1994) Bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopathology, 25, 77-82.
24. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H. G., Irie, S., Fong, L., Reed, J. C. (1994) Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res., 54, 5501-5507.
25. Schlaifer, D., March, M., Krajewski, S., Laurent, G., Pris, J., Delsol, G., Reed, J. C., Brousset, P. (1995) High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood, 85, 2671-2674.
26. Park, J. R., Bernstein, I. D., Hockenbery, D. M. (1995) Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood, 86, 868-876.
27. Stetler-Stevenson, M , Crash-Stanton, S., Cossman, J. (1990) Involvement of the bcl-2 gene in Hodgkin's disease. J. Natl. Cancer Inst., 82, 855-858.
28. Louie, D. C., Kant, J. A., Brooks, J. J., Reed, J. C. (1991) Absence of t(14:18) major and minor breakpoints and of bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease. Am. J. Pathol., 139, 1231-1237.
29. Cabanillas, F., Pathak, S., Trujillo, J., Grant, G., Cork, A., Hagemeister, F., Velasquez, W., McLaughlin, P., Redman, J., Katz, R., Butler, J., Freireich, E. (1988) Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte. Blood, 71, 1615-1617.
30. Corbally, N., Grogan, L., Keane, M. M., Devaney, D. M., Dervan, P. A., Carney, D. N. (1994) Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes. Am. J. Clin. Pathol., 101, 756-760.
31. Chao, D. T., Linette, G. P., Boise, L. H., White, L. S., Thompson, C. B., Korsmeyer, S. J (1995) Bcl-x-L and Bcl-2 repress a common pathway of cell death. J. Exp. Med., 182, 821-828.
32. Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., Craig, R. W. (1993) MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci USA, 90, 3516-3520.
33. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., Korsmeyer, S. J. (1995) Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell, 80, 285-291.
34. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J. A., Reed, J. C. (1995) Cloning and functional analysis of BAG-1: a novel bcl-2-binding protein with anti-cell death activity. Cell, 80, 279-284
35. Minn, A. J., Rudin, C. M., Boise, L. H., Thompson, C. B. (1995) Expression of Bcl-x-L can confer a multidrug resistance phenotype Blood, 86, 1903-1910.
36. Haber, D A. (1992) Multidrug resistance (MDR1) in leukemia: is it time to test? Blood, 79, 295-298.
37. Schlaifer, D., Duchayne, E., Demur, C., Alvinerie, P., Muller, C , Attal, M., Cooper, M. R., Payen, C., Monsarrat, B., Myers, C. E., Pris, J., Laurent, G. (1995) Vincristine degradation by serum from leukemic patients: role of myeloperoxidase. Leuk. Lymph., 18, 179-184.
38. Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Nunez, G., Castle, V. P. (1995) Bcl-x-L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res., 55, 2576-2582.
39. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F., Wicha, M. S. (1995) Overexpression of Bcl-x-S sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55, 2507-2510.